1. The Royal College of radiologists. iRefer: Making the best use of clinical radiology, 7th edition. London: The Royal college of Radiologists, 2012.
2. Delivanis D.A., Castro M.R. (2018). Thyroid Nodules. Humana Press; Cham, Switzerland: 2017. Thyroid Incidentalomas; pp. 153–167.
3. Vassiliadi D.A., Tsagarakis S. Endocrine Incidentalomas—Challenges Imposed by Incidentally Discovered Lesions. National review of endocrinology, 2011; June 28th; 7:668–680. Doi: 10.1038/nrendo.2011.92
4. Kao YH, Lim SS, Ong SC, Padhy AK. Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: Incidence, malignancy risk, and comparison of standardized uptake values. Cancer Associated Radiology Journal, 2012; 63:289-93
5. Soelberg KK, Bonnema SJ, Brix TH, Hegedüs L. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid 2012; 22: 918–25. Doi:
6. Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, et al. (2001) Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 130: 941–946.
7. Kang KW, Kim SK, Kang HS, Lee ES, Sim JS, et al. (2003) Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. Journal Clinical Endocrinology Metabolism 88: 4100–4104.
8. Chen YK, Ding HJ, Chen KT, Chen YL, Liao AC, et al. (2005) Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Research. 25: 1421–1426.
9. Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A (2009) Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nuclear Medicine Community. 30(3): 240–244.
10. Yi JG, Marom EM, Munden RF, Truong MT, Macapinlac HA, et al. (2005) Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non–small cell lung cancer. Radiology 236: 271–275.
11.Ho TY, Liou MJ, Lin KJ, Yen TC (2011) Prevalence and significance of thyroid uptake detected by 18F-FDG PET. Endocrine. 40(2): 297–302.
12.Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, et al. (2005) 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 115: 1074–1078.
13. Chu QD, Connor MS, Lilien DL, Johnson LW, Turnage RH, et al. (2006) Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center. American Surgery. 72(3): 272–275.
14. Bae JS, Chae BJ, Park WC, Kim JS, Kim SH, et al. (2009) Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer. World Journal of Surgical Oncology. 7: 63.
15 Pencharz D, Nathan M, Wagner TL. Evidence-based management of incidental focal uptake of fluorodeoxyglucose on PET-CT. British Journal of Radiology, 2018; 91: 20170774.
16. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016; 26: 1–133. doi: https://doi.org/ 10.1089/thy.2015.0020
17. Hoang JK, Langer JE, Middleton WD, Wu CC, Hammers LW, Cronan JJ, et al. Managing incidental thyroid nodules detected on imaging: white paper of the ACR incidental thyroid findings committee. J Am Coll Radiol 2015; 12: 143–50. doi: https://doi. org/10.1016/j.jacr.2014.09.038
18. Chu Y, Zheng A, Wang F, Lin W, Yang X, Han L, et al. Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: A systematic review and meta-analysis. Nuclear Medicine Community 2014; 35:144-50
19. Kumar V, Nath K, Berman CG, Kim J, Tanvetyanon T, et al. (2013) Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings. Clinical Nuclear Medicine 38(3): 175–82
20. J.A. Eloy, E.M. Brett, G.M. Fatterpekar, L. Kostakoglu, P.M. Som, S.C. Desai, E.M. Genden, The Significance and Management of Incidental [18F]Fluorodeoxyglucose–Positron-Emission Tomography Uptake in the Thyroid Gland in Patients with Cancer, American Journal of Neuroradiology Aug 2009, 30 (7) 1431-1434; DOI: 10.3174/ajnr.A1559
21. Are C, Hsu JF, Schoder H, Shah JP, Larson SM, et al. (2007) FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol 14: 239–247